Sciatica
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical study. A total of 196 people meeting the eligibility criteria will be probabilistically allocated to one or another intervention group u
Sponsors
Carmens Medicinal
Carmens Medicinal
Eligibility
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients undergoing follow-up at the Spine Surgery and/or Antalgic Therapy and Palliative Care Outpatient from the Hospital of the Faculty of Medicine of Botucatu with pain in the lumbar spine with associated sciatica (low back pain); Age between 18 and 75 years; Be able to respond to the questionnaires proposed in the research; both genders.
Exclusion criteria
Exclusion criteria: Pregnant women; Patient with fracture or neoplastic lesion; Patients with pathologies that cause electrolyte disorders; Cognitive inability to adequately respond to questionnaires; Disagree with the free and informed consent form; Patient with low back pain without sciatica; Recreational users of illicit substances.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attenuation of neuropathic pain in low back pain with the use of cannabinoids. Evaluated through the use of Pain assessment scales, will be expected to find a statistical decrise in Pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improved functionality after use of cannabinoids. Assessed using the Oswestry Disability Index (ODI);Improvement in quality of life after using cannabinoids.;Quantifying the need for analgesics during and after treatment with cannabinoids. | — |
Countries
Brazil
Contacts
Public ContactDênis Queiroz
Universidade Estadual Paulista
Outcome results
None listed